The global veterinary CRO and CDMO market size is calculated at USD 7.73 billion in 2025 and is forecasted to reach around USD 15.98 billion by 2034, accelerating at a CAGR of 8.40% from 2025 to 2034. The North America veterinary CRO and CDMO market size surpassed USD 2.57 billion in 2024 and is expanding at a CAGR of 8.42% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary CRO and CDMO Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary CRO and CDMO Market, by Animal Type
8.1.1 Companion Animals
8.1.1.1. Market Revenue and Forecast
8.1.2. Livestock Animals
8.1.2.1. Market Revenue and Forecast
9.1. Veterinary CRO and CDMO Market, by Service Type
9.1.1. Discovery
9.1.1.1. Market Revenue and Forecast
9.1.2. Development
9.1.2.1. Market Revenue and Forecast
9.1.3. Manufacturing
9.1.3.1. Market Revenue and Forecast
9.1.4. Packaging & Labeling
9.1.4.1. Market Revenue and Forecast
9.1.5. Market Approval & Post-marketing
9.1.5.1. Market Revenue and Forecast
10.1. Veterinary CRO and CDMO Market, by Application
10.1.1. Medicines
10.1.1.1. Market Revenue and Forecast
10.1.2. Medical Devices
10.1.2.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Animal Type
11.1.2. Market Revenue and Forecast, by Service Type
11.1.3. Market Revenue and Forecast, by Application
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Animal Type
11.1.4.2. Market Revenue and Forecast, by Service Type
11.1.4.3. Market Revenue and Forecast, by Application
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Animal Type
11.1.5.2. Market Revenue and Forecast, by Service Type
11.1.5.3. Market Revenue and Forecast, by Application
11.2. Europe
11.2.1. Market Revenue and Forecast, by Animal Type
11.2.2. Market Revenue and Forecast, by Service Type
11.2.3. Market Revenue and Forecast, by Application
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Animal Type
11.2.4.2. Market Revenue and Forecast, by Service Type
11.2.4.3. Market Revenue and Forecast, by Application
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Animal Type
11.2.5.2. Market Revenue and Forecast, by Service Type
11.2.5.3. Market Revenue and Forecast, by Application
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Animal Type
11.2.6.2. Market Revenue and Forecast, by Service Type
11.2.6.3. Market Revenue and Forecast, by Application
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Animal Type
11.2.7.2. Market Revenue and Forecast, by Service Type
11.2.7.3. Market Revenue and Forecast, by Application
11.3. APAC
11.3.1. Market Revenue and Forecast, by Animal Type
11.3.2. Market Revenue and Forecast, by Service Type
11.3.3. Market Revenue and Forecast, by Application
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Animal Type
11.3.4.2. Market Revenue and Forecast, by Service Type
11.3.4.3. Market Revenue and Forecast, by Application
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Animal Type
11.3.5.2. Market Revenue and Forecast, by Service Type
11.3.5.3. Market Revenue and Forecast, by Application
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Animal Type
11.3.6.2. Market Revenue and Forecast, by Service Type
11.3.6.3. Market Revenue and Forecast, by Application
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Animal Type
11.3.7.2. Market Revenue and Forecast, by Service Type
11.3.7.3. Market Revenue and Forecast, by Application
11.4. MEA
11.4.1. Market Revenue and Forecast, by Animal Type
11.4.2. Market Revenue and Forecast, by Service Type
11.4.3. Market Revenue and Forecast, by Application
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Animal Type
11.4.4.2. Market Revenue and Forecast, by Service Type
11.4.4.3. Market Revenue and Forecast, by Application
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Animal Type
11.4.5.2. Market Revenue and Forecast, by Service Type
11.4.5.3. Market Revenue and Forecast, by Application
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Animal Type
11.4.6.2. Market Revenue and Forecast, by Service Type
11.4.6.3. Market Revenue and Forecast, by Application
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Animal Type
11.4.7.2. Market Revenue and Forecast, by Service Type
11.4.7.3. Market Revenue and Forecast, by Application
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Animal Type
11.5.2. Market Revenue and Forecast, by Service Type
11.5.3. Market Revenue and Forecast, by Application
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Animal Type
11.5.4.2. Market Revenue and Forecast, by Service Type
11.5.4.3. Market Revenue and Forecast, by Application
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Animal Type
11.5.5.2. Market Revenue and Forecast, by Service Type
11.5.5.3. Market Revenue and Forecast, by Application
12.1. Covance Inc. (a LabCorp Company)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Charles River Laboratories International, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. PAREXEL International Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ICON plc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Pharmaceutical Product Development, LLC (PPD)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Syneos Health
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. WuXi AppTec
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medpace
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Envigo
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Vetio Animal Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample